Secreted phosphoprotein 1 as a potential prognostic and immunotherapy biomarker in multiple human cancers-Reference-Cited by-同舟云学术

Secreted phosphoprotein 1 as a potential prognostic and immunotherapy biomarker in multiple human cancers

Published:2022-01-22 Issue:2 Volume:13 Page:3221-3239
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Zeng Ping¹,Zhang Xujun¹,Xiang Tianxin²,Ling Zongxin¹,Lin Chenhong¹,Diao Hongyan¹

Affiliation:

1. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

2. Department of Hospital Infection Control, The First Affiliated Hospital of Nanchang University, Nanchang, China

Funder

National Key Research and Development Program of China

the Key Research & Developement Plan of Zhejiang Province

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.2020391

Reference63 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries